Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

Understanding the Medicare Prescription Drug Rebate - Issue Brief

The Inflation Reduction Act: A tale of two drugs - Putnam

Weekly eJournal From CorroHealth, April 26, 2023 by CorroHealth

Explaining the Prescription Drug Provisions in the Build Back

Mitigating the Inflation Reduction Act's Adverse Impacts on the

Mintz IRA Update — Other Key IRA Programs and Developments: The

The Inflation Reduction Act: A tale of two drugs - Putnam

News ASHRM

Issue Brief: The Big Government Socialism Bill Jeopardizes the

Chart: The Ever-Increasing Cost of Medicare Drugs

Explaining the Prescription Drug Provisions in the Inflation

Inflation Reduction Act Continues to Lower Out-of-Pocket

New Guidance on Medicare Inflation Rebates Adjusts for Drug

A Comparison of Brand-Name Drug Prices Among Selected Federal